Citation Impact
Citing Papers
Innate and Adaptive Immunity Cooperate Flexibly to Maintain Host-Microbiota Mutualism
2009 StandoutScienceNobel
Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease.
1993
Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes.
1994
Differential expression of CD25 (interleukin-2 receptor) on lamina propria T cells and macrophages in the intestinal lesions in Crohn's disease and ulcerative colitis.
1990
Recent developments in esophageal adenocarcinoma
2013
Selective Cyclooxygenase-2 Inhibition by Nimesulide in Man
1998
Elevation of interleukin-6 in inflammatory bowel disease is macrophage- and epithelial cell-dependent
1995
Expression of adhesion molecules and HLA-DR by macrophages and dendritic cells in aphthoid lesions of Crohn's disease: An immunocytochemical study
1994
Lansoprazole for the Prevention of Recurrences of Ulcer Complications from Long-Term Low-Dose Aspirin Use
2002 Standout
Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum
1998
Inflammation and cancer
2002 StandoutNature
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2013 Standout
Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
1995 StandoutNobel
Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease
1999 Standout
The mucosal addressin cell adhesion molecule antibody PF-00547,659 in ulcerative colitis: a randomised study
2011
Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis
2005 Standout
Bowel Disorders
2016 Standout
The role of cyclooxygenases in inflammation, cancer, and development
1999
Intestinal homeostasis and its breakdown in inflammatory bowel disease
2011 StandoutNature
Ulcerative Colitis
2011 Standout
Natalizumab Induction and Maintenance Therapy for Crohn's Disease
2005
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility
2016 Standout
Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans
1993
Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2
2000 StandoutNobel
Endometriosis
2009 Standout
Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
1990 Standout
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Rhabdomyolysis and Acute Kidney Injury
2009 Standout
Nonsteroidal anti-inflammatory drug-induced gastrointestinal injury
1996
Natalizumab for Active Crohn's Disease
2003
Elimination of Local Macrophages in Intestine Prevents Chronic Colitis in Interleukin-10-Deficient Mice
2003 StandoutNobel
Synthesis and biological evaluation of substituted 2-sulfonyl-phenyl-3-phenyl-indoles: a new series of selective COX-2 inhibitors
2003
Thyroid associated ophthalmopathy: evidence for CD4+ T cells; de novo differentiation of RFD7+ macrophages, but not of RFD1+ dendritic cells; and loss of and T cell receptor expression
2004
A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease
1997 Standout
Immune activation genes in inflammatory bowel disease
1993
Inflammatory Bowel Disease
2009 Standout
T‐cell cytokines may control the balance of functionally distinct macrophage populations
1997
The Key Role of Macrophages in the Immunopathogenesis of Inflammatory Bowel Disease
2000
Cloning, Expression, and Up-regulation of Inducible Rat Prostaglandin E Synthase during Lipopolysaccharide-induced Pyresis and Adjuvant-induced Arthritis
2001
Intestinal macrophages: unique effector cells of the innate immune system
2005
Inflammatory Bowel Disease
1991 Standout
Platelet Activation and Atherothrombosis
2007 Standout
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
2001 StandoutNature
Graves' Ophthalmopathy
2010 Standout
Inflammatory Bowel Disease
2002 Standout
Natalizumab for the Treatment of Active Crohn’s Disease: Results of the ENCORE Trial
2007
Novel approaches to treating inflammatory bowel disease: targeting alpha-4 integrin
2003
Inhibition by interleukin-1 of the action of erythropoietin on erythroid precursors and its possible role in the pathogenesis of hypoplastic anaemias
1987
Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease
1991
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
2002 Standout
Direct evidence of monocyte recruitment to inflammatory bowel disease mucosa
1995
Increased numbers of macrophages in noninflamed gastroduodenal mucosa of patients with Crohn's disease
1996
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
2006 Standout
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
Inherited disorders of coagulation appear to protect against inflammatory bowel disease
1995
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
1999 Standout
Lack of Renoprotective Effects of Dopamine and Furosemide during Cardiac Surgery
2000
Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans
1999
Indocyanine Green: Physicochemical Factors Affecting Its Fluorescencein Vivo
1998
Atherosclerosis — An Inflammatory Disease
1999 Standout
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
2012 Standout
The Human Microbiome Project
2007 StandoutNature
Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's Disease
2005
Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages
2007 StandoutNobel
Eicosanoids and the gastrointestinal tract
1995
Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents
1996 StandoutNature
A guideline for the treatment and prevention of NSAID-induced ulcers
1998
Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout
2005 Standout
Inflammatory bowel disease: Etiology and pathogenesis
1998 Standout
Tumor necrosis factor α-producing cells in the intestinal mucosa of children with inflammatory bowel disease
1994
Acute renal failure
2005
Intestinal macrophages and response to microbial encroachment
2010
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
1995 Standout
Intensive Insulin Therapy in Critically Ill Patients
2001 Standout
Management of Acute and Chronic Gouty Arthritis
2004
COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice
2002
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
Reactive Oxygen Species‐Scavenging Nanomedicines for the Treatment of Oxidative Stress Injuries
2014
RAPID REVERSAL OF HYPEROXALURIA IN A RAT MODEL AFTER PROBIOTIC ADMINISTRATION OF OXALOBACTER FORMIGENES
2001
Evidence for a CD14+ population of monocytes in inflammatory bowel disease mucosa—implications for pathogenesis
1995
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Inorganic nanoparticles in porous coordination polymers
2016 StandoutNobel
Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ
2001 StandoutScience
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
2001 StandoutScience
Transition-Metal-Catalyzed C−S, C−Se, and C−Te Bond Formation via Cross-Coupling and Atom-Economic Addition Reactions
2011 Standout
Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase
1995
Development of an Oral Drug Delivery System Targeting Immune-Regulating Cells in Experimental Inflammatory Bowel Disease: A New Therapeutic Strategy
2000
Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes
1997 StandoutScience
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
The Intestinal Microvasculature as a Therapeutic Target in Inflammatory Bowel Disease
2006
Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation.
1992
MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands
2010 StandoutNobel
Global cancer statistics, 2012
2015 Standout
Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine
1990
International experiences with the Hospital Anxiety and Depression Scale-A review of validation data and clinical results
1997 Standout
Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain.
1994
Are There Differences Among Nonsteroidal Antiinflammatory Drugs?
1994
Growth and activities of sulphate-reducing bacteria in gut contents of healthy subjects and patients with ulcerative colitis
1991
An Oral Drug Delivery System Targeting Immune-Regulating Cells Ameliorates Mucosal Injury in Trinitrobenzene Sulfonic Acid-Induced Colitis
2001
Works of M C Allison being referenced
Neoterminal ileal blood flow after ileocolonic resection for Crohn's disease.
1993
Evaluating children in the Ukraine for colonization with the intestinal bacterium Oxalobacter formigenes, using a polymerase chain reaction-based detection system*
1997
Psychiatric Disorder and Outcome in Irritable Bowel Syndrome
1996
Multidisciplinary team management is associated with improved outcomes after surgery for esophageal cancer
2006
Immunohistological studies of surface antigen on colonic lymphoid cells in normal and inflamed mucosa
1990
Gastrointestinal Damage Associated with the Use of Nonsteroidal Antiinflammatory Drugs
1992
Loop diuretics in the management of acute renal failure: a prospective, double-blind, placebo-controlled, randomized study
1997
A randomized placebo-controlled trial of a humanized monoclonal antibody to α4 integrin in active crohn's disease
2001
Mucosal capillary thrombi in rectal biopsies
1992
Prevalence of proximal faecal stasis in active ulcerative colitis.
1991
Changes in phenotypically distinct mucosal macrophage populations may be a prerequisite for the development of inflammatory bowel disease
1991
Macrophage heterogeneity in normal colonic mucosa and in inflammatory bowel disease.
1988
Steroid sensitive systemic disease with anaemia in the elderly: a manifestation of giant cell arteritis?
1985